OpenVSafe by OpenVAERS
Search V-safe

F9H-61040-15648

5 vaccinations 6 coded responses 38 check-ins 6 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
342 / FL
Registered
2021-01-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2540672 (opens in a new window) high 10 / 11 4 2 of 8 VAERS symptoms same dose (5) FL matches 2022-09-21 / 2022-12-02 / 2022-12-22
received the same day as the last call
case 1233588

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-01-21
    Dose 1 — Moderna
  2. 2021-01-22
    Registered in v-safe
  3. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  4. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness · Fatigue or tiredness
    Adult check-in
  5. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-30
    Survey response — day 7, dose 1
    MedDRA: Fatigue, Injection site rash, Injection site warmth — Feeling: Fair · Site: Pain, Redness · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Rash appeared at injection site 7 days after injection accompanied by fatigue that resulted in 18 hours of sleep in 24 hours. Rash is very noticeably warm.warm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-04
    Survey response — day 14, dose 1
    MedDRA: Fatigue, Injection site rash, Injection site warmth — Feeling: Good · Be unable to work
    Free text: On day 7 - 9 had warm red rash at injection site. Also experienced fatigue especially on day 7 - slept 18 hrs instead of usual 8.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-12
    Survey response — day 21, dose 1
    MedDRA: Fatigue, Injection site rash — Feeling: Good · Be unable to work
    Free text: Rash at injection site and fatigue days 7 - 9 post injection.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-15
    Dose 2 — Moderna
  12. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  14. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-03-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-17
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-08-16
    Survey response — 6 months, dose 2
    MedDRA: Abdominal pain, Diarrhoea, Fatigue, Oropharyngeal pain — Feeling: Fair
    Free text: Diarrhea, fatigue mild sore throat and abdominal soreness.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  20. 2021-10-26
    Dose 3 — Moderna
  21. 2021-10-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  22. 2021-10-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  23. 2021-10-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-11-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2021-11-04
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  26. 2021-11-11
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-11-23
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  28. 2021-11-30
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  29. 2022-04-16
    Dose 4 — Moderna
  30. 2022-04-18
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  31. 2022-04-21
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  32. 2022-04-25
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  33. 2022-04-30
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-05-09
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-05-16
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-05-21
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-05-28
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-07-16
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-09-21
    Dose 5 — Moderna
  40. 2022-10-06
    Survey response — day 14, dose 5
    MedDRA: Urinary tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Complicated UTI
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-10-06
    Report sent to call center — day 14, dose 5
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  42. 2022-10-07
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  43. 2022-10-21
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  44. 2022-10-26
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  45. 2022-11-02
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  46. 2022-12-21
    Survey response — 3 months, dose 5
    MedDRA: COVID-19, Hospitalisation, Intensive care — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Symptoms: Positive for COVID. Hospitalized for 8 days. In ICU for 3 days. · Healthcare visit (other): Hospital 8 days. ICU 3 DAYS
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-12-21
    Report sent to call center — 3 months, dose 5
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  48. 2022-12-22
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Moderna
22021-02-15Moderna
32021-10-26Moderna No
42022-04-16Moderna No
52022-09-21Moderna No

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 3 — day 7, dose 1

2021-01-30

Systemic reaction (other): Rash appeared at injection site 7 days after injection accompanied by fatigue that resulted in 18 hours of sleep in 24 hours. Rash is very noticeably warm.warm

Release 3 — day 14, dose 1

2021-02-04

Symptoms: On day 7 - 9 had warm red rash at injection site. Also experienced fatigue especially on day 7 - slept 18 hrs instead of usual 8.

Release 4 — day 21, dose 1

2021-02-12

Symptoms: Rash at injection site and fatigue days 7 - 9 post injection.

Release 9 — 6 months, dose 2

2021-08-16

Symptoms: Diarrhea, fatigue mild sore throat and abdominal soreness.

Release 12 — day 14, dose 5

2022-10-06

Symptoms: Complicated UTI

Release 12 — 3 months, dose 5

2022-12-21

Symptoms: Positive for COVID. Hospitalized for 8 days. In ICU for 3 days.
Healthcare visit (other): Hospital 8 days. ICU 3 DAYS

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOHospitalisation · · ✓
HCVOIntensive care · · ✓
SDAbdominal pain ✓ · ✓
SDCOVID-19 · · ✓
SDDiarrhoea ✓ · ✓
SDFatigue ✓ ✓ ✓
SDHospitalisation · · ✓
SDInjection site rash ✓ ✓ ✓
SDInjection site warmth ✓ ✓ ✓
SDIntensive care · · ✓
SDOropharyngeal pain ✓ · ✓
SDUrinary tract infection · · ✓
SROFatigue ✓ ✓ ✓
SROInjection site rash ✓ ✓ ✓
SROInjection site warmth ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release